ANCA defines the clinical disease manifestations of vasculitis

Sarcoidosis Vasc Diffuse Lung Dis. 1996 Oct;13(3):221-6.

Authors

M H Zhao¹, C M Lockwood

Affiliation

¹ Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, UK.

PMID: 8946586

No abstract available

Publication types

Review

MeSH terms

Antibodies, Antineutrophil Cytoplasmic / immunology*
Antibody Specificity
Antigens, CD / immunology
Antimicrobial Cationic Peptides
Autoantigens / immunology*
Blood Proteins / immunology
Carrier Proteins*
Defensins
Humans
Lysosomal Membrane Proteins
Membrane Glycoproteins / immunology
Myeloblastin
Peroxidase / immunology
Serine Endopeptidases / immunology
Vasculitis / immunology*

Substances

AZU1 protein, human
Antibodies, Antineutrophil Cytoplasmic
Antigens, CD
Antimicrobial Cationic Peptides
Autoantigens
Blood Proteins
Carrier Proteins
Defensins
Lysosomal Membrane Proteins
Membrane Glycoproteins
cationic antimicrobial protein 57, human
Peroxidase
Serine Endopeptidases
Myeloblastin